keyword
https://read.qxmd.com/read/38426593/editorial-for-beta-catenin-mutated-hepatocellular-adenomas-at-hepatobiliary-phase-mri-a-systematic-review-and-meta-analysis
#21
EDITORIAL
Sabine Schmidt, Christine Sempoux
No abstract text is available yet for this article.
March 1, 2024: Journal of Magnetic Resonance Imaging: JMRI
https://read.qxmd.com/read/38411871/liver-imaging-and-pregnancy-what-to-expect-when-your-patient-is-expecting
#22
REVIEW
Giorgia Porrello, Roberto Cannella, Jacques Bernuau, Antoine Agman, Giuseppe Brancatelli, Marco Dioguardi Burgio, Valérie Vilgrain
Liver diseases in pregnancy can be specific to gestation or only coincidental. In the latter case, the diagnosis can be difficult. Rapid diagnosis of maternal-fetal emergencies and situations requiring specialized interventions are crucial to preserve the maternal liver and guarantee materno-fetal survival. While detailed questioning of the patient and a clinical examination are highly important, imaging is often essential to reach a diagnosis of these liver diseases and lesions. Three groups of liver diseases may be observed during pregnancy: (1) diseases related to pregnancy: intrahepatic cholestasis of pregnancy, pre-eclampsia, eclampsia, hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome, and acute fatty liver of pregnancy; (2) liver diseases that are more frequent during or exacerbated by pregnancy: acute herpes simplex hepatitis, Budd-Chiari syndrome, hemorrhagic hereditary telangiectasia, hepatocellular adenoma, portal vein thrombosis, and cholelithiasis; (3) coincidental conditions, including acute hepatitis, incidental focal liver lesions, metabolic dysfunction-associated steatotic liver disease, cirrhosis, hepatocellular carcinoma, liver abscesses and parasitosis, and liver transplantation...
February 27, 2024: Insights Into Imaging
https://read.qxmd.com/read/38393453/the-contribution-of-ultrasound-in-the-diagnostic-pathway-of-a-symptomatic-hepatocellular-adenoma-arising-from-ectopic-liver
#23
JOURNAL ARTICLE
Nicholas Vanigli, Laura Melotti, Nikolas Dussias, Amalia Sanna Passino, Elena Mazzotta, Chiara De Molo, Lorenzo Gentilini, Gilberto Poggioli, Paolo Gionchetti, Fernando Rizzello
Ectopic liver (EL) is a rare congenital anomaly characterized by the presence of a mass composed of hepatic tissue localized in a different anatomical location with no connection to the native liver. Usually an incidental finding, EL can rarely cause symptoms such as abdominal pain due to torsion, intraperitoneal bleeding, compression, obstruction, or neoplastic transformation, both benign and malignant. EL is often suspected after instrumental investigations such as ultrasound, CT and MRI, however a definitive diagnosis is necessarily bioptic...
February 23, 2024: Journal of Ultrasound
https://read.qxmd.com/read/38361782/hepatic-perivascular-epithelioid-cell-tumor-resembling-hepatic-adenoma-and-hepatocellular-carcinoma-on-preoperative-imaging-a-case-report
#24
Dongling Zhu, Shuang Song, Dongdong Wang, Dong Kuang, Siyuan Cheng, Jianyuan Zhou, Sijuan Zou
Perivascular epithelioid cell tumor (PEComa), an uncommon mesenchymal neoplasm, arises from specialized perivascular epithelioid cells exhibiting distinct features of smooth muscle and melanocytic differentiation with unpredictable behavior. PEComa tends to occur more commonly in the uterus and kidneys; its occurrence in the liver is exceedingly rare. We presented a case of a 29-year-old woman with hepatic PEComa and evaluated the tumor with MRI, integrated 18 F-fluorodeoxyglucose (FDG), and 68 Ga-fibroblast activation protein inhibitor (FAPI) PET/CT scans at presentation...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38313384/spontaneous-hepatic-hemorrhage-causing-acute-liver-failure-requiring-liver-transplant
#25
Krunal Shukla, Rahul Chaudhari, Amon Asgharpour
Spontaneous hepatic hemorrhage (SHH) is a very rare but life-threatening entity that results from a breach in the hepatic parenchyma without any external cause, the most common being hepatocellular carcinoma and hepatic adenoma. We present a case of SHH without any underlying tumor or injury. The cause in our patient remained unclear, but we hypothesize that the patient's SHH was most likely coagulopathy-related.
February 2024: ACG Case Reports Journal
https://read.qxmd.com/read/38312995/hepatocellular-adenomas-hcas-and-pregnancy
#26
REVIEW
Jennifer Guy
No abstract text is available yet for this article.
2024: Clinical Liver Disease
https://read.qxmd.com/read/38304236/spatial-characterisation-of-%C3%AE-catenin-mutated-hepatocellular-adenoma-subtypes-by-proteomic-profiling-of-the-tumour-rim
#27
JOURNAL ARTICLE
Sylvaine Di Tommaso, Cyril Dourthe, Jean-William Dupuy, Nathalie Dugot-Senant, David Cappellen, Hélène Cazier, Valérie Paradis, Jean-Frédéric Blanc, Brigitte Le Bail, Charles Balabaud, Paulette Bioulac-Sage, Frédéric Saltel, Anne-Aurélie Raymond
BACKGROUND & AIMS: Hepatocellular adenomas (HCAs) are rare, benign, liver tumours classified at the clinicopathological, genetic, and proteomic levels. The β-catenin-activated (b-HCA) subtypes harbour several mutation types in the β-catenin gene ( CTNNB1 ) associated with different risks of malignant transformation or bleeding. Glutamine synthetase is a surrogate marker of β-catenin pathway activation associated with the risk of malignant transformation. Recently, we revealed an overexpression of glutamine synthetase in the rims of exon 3 S45-mutated b-HCA and exon 7/8-mutated b-HCA compared with the rest of the tumour...
February 2024: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/38298321/comparing-texture-analysis-of-apparent-diffusion-coefficient-mri-in-hepatocellular-adenoma-and-hepatocellular-carcinoma
#28
JOURNAL ARTICLE
Ayoob Dinar Abdullah, Behzad Amanpour-Gharaei, Mohssen Nassiri Toosi, Sina Delazar, Hamidraza Saligheh Rad, Arvin Arian
AIM: This study aimed to assess the effectiveness of using MRI-apparent diffusion coefficient (ADC) map-driven radiomics to differentiate between hepatocellular adenoma (HCA) and hepatocellular carcinoma (HCC) features. MATERIALS AND METHODS: The study involved 55 patients with liver tumors (20 with HCA and 35 with HCC), featuring 106 lesions equally distributed between hepatic carcinoma and hepatic adenoma who underwent texture analysis on ADC map MR images. The analysis identified several imaging features that significantly differed between the HCA and HCC groups...
January 2024: Curēus
https://read.qxmd.com/read/38280744/hepatic-precancerous-lesions-and-early-hepatocellular-carcinoma
#29
REVIEW
Kwun Wah Wen, Sanjay Kakar
This review discusses the diagnostic challenges of diagnosing and treating precursor lesions of hepatocellular carcinoma (HCC) in both cirrhotic and non-cirrhotic livers. The distinction of high-grade dysplastic nodule (the primary precursor lesion in cirrhotic liver) from early HCC is emphasized based on morphologic, immunohistochemical, and genomic features. The risk factors associated with HCC in hepatocellular adenomas (precursor lesion in non-cirrhotic liver) are delineated, and the risk in different subtypes is discussed with emphasis on terminology, diagnosis, and genomic features...
March 2024: Gastroenterology Clinics of North America
https://read.qxmd.com/read/38254797/histopathological-spectrum-and-molecular-characterization-of-liver-tumors-in-the-setting-of-fontan-associated-liver-disease
#30
JOURNAL ARTICLE
Paola Francalanci, Isabella Giovannoni, Chantal Tancredi, Maria Giulia Gagliardi, Rosalinda Palmieri, Gianluca Brancaccio, Marco Spada, Giuseppe Maggiore, Andrea Pietrobattista, Lidia Monti, Aurora Castellano, Maria Cristina Giustiniani, Andrea Onetti Muda, Rita Alaggio
PURPOSE: Univentricular heart is corrected with the Fontan procedure (FP). In the long term, so-called Fontan-associated liver diseases (FALDs) can develop. The aim of this study is to analyze the molecular profile of FALDs. METHODS: FALDs between January 1990 and December 2022 were reviewed for histology and immunohistochemistry, laboratory data, and images. Targeted next generation sequencing (NGS), performed on the DNA and RNA of both neoplastic and non-lesional liver tissue, was applied...
January 11, 2024: Cancers
https://read.qxmd.com/read/38238954/-analysis-of-mri-features-of-hepatocyte-nuclear-factor-1%C3%AE-inactivated-hepatocellular-adenoma
#31
JOURNAL ARTICLE
H Pan, X F Chen, J Han, Y Ji, M S Zeng, M L Wang
Objective: To investigate the MRI imaging features of hepatocyte nuclear factor 1α- inactivated hepatocellular adenoma (H-HCA). Methods: Clinical data and MRI images of 19 H-HCA cases who were pathologically confirmed at Zhongshan Hospital Affiliated to Fudan University between August 2014 and July 2020 were retrospectively analyzed. Among them, there were 15 females and 4 males, aged 16-47 (32± 7) years old. Tumor number, location, shape, size, boundary, MRI plain scan signal intensity, dynamic enhancement features of each phase, presence or absence of intratumoral fat content, pseudocapsule, and others were analyzed...
November 20, 2023: Zhonghua Gan Zang Bing za Zhi, Zhonghua Ganzangbing Zazhi, Chinese Journal of Hepatology
https://read.qxmd.com/read/38238953/-clinical-and-pathological-features-of-20-cases-of-congenital-hepatic-fibrosis
#32
JOURNAL ARTICLE
A Wang, Z J Lu, X F Gu, J P Liu, C L Lu
Objective: To investigate the clinical and pathological features of congenital hepatic fibrosis (CHF). Methods: The clinical and pathological findings of 20 patients diagnosed with CHF from 2017 to 2023 were retrospectively analyzed. Results: Among the 20 patients, 8 were males and 12 were females with a median age of 21.5 years. Mostly patients were admitted to the hospital with cirrhosis, portal hypertension and upper gastrointestinal bleeding. Pathological features were diffuse fibrosis in the portal area, formation of fibrous septa of varying width, segmentation of the liver parenchyma, with hyperplasia of small bile ducts...
November 20, 2023: Zhonghua Gan Zang Bing za Zhi, Zhonghua Ganzangbing Zazhi, Chinese Journal of Hepatology
https://read.qxmd.com/read/38234409/expert-management-of-congenital-portosystemic-shunts-and-their-complications
#33
REVIEW
Valérie Anne McLin, Stéphanie Franchi-Abella, Timothée Brütsch, Atessa Bahadori, Valeria Casotti, Jean de Ville de Goyet, Grégoire Dumery, Emmanuel Gonzales, Florent Guérin, Sebastien Hascoet, Nigel Heaton, Béatrice Kuhlmann, Frédéric Lador, Virginie Lambert, Paolo Marra, Aurélie Plessier, Alberto Quaglia, Anne-Laure Rougemont, Laurent Savale, Moinak Sen Sarma, Olivier Sitbon, Riccardo Antonio Superina, Hajime Uchida, Mirjam van Albada, Hubert Petrus Johannes van der Doef, Valérie Vilgrain, Julie Wacker, Nitash Zwaveling, Dominique Debray, Barbara Elisabeth Wildhaber
Congenital portosystemic shunts are often associated with systemic complications, the most challenging of which are liver nodules, pulmonary hypertension, endocrine abnormalities, and neurocognitive dysfunction. In the present paper, we offer expert clinical guidance on the management of liver nodules, pulmonary hypertension, and endocrine abnormalities, and we make recommendations regarding shunt closure and follow-up.
January 2024: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/38201587/phospholipase-a2-group-iia-is-associated-with-inflammatory-hepatocellular-adenoma
#34
JOURNAL ARTICLE
Sadahiro Iwabuchi, Kenta Takahashi, Kazunori Kawaguchi, Akihisa Nagatsu, Tadashi Imafuku, Shigeyuki Shichino, Kouji Matsushima, Akinobu Taketomi, Masao Honda, Shinichi Hashimoto
Although benign hepatocellular adenomas (HCA) are very rare, recent observations have shown their occurrence in patients with diabetes mellitus. Consequently, most of these cases are treated by resection due to concerns regarding their potential progression to hepatocarcinoma (HCC). This decision is largely driven by the limited number of studies on HCC subtyping and the lack of molecular and biological insights into the carcinogenic potential of benign tumors. This study aimed to comprehensively investigate the subtype classification of HCA and to compare and analyze gene expression profiling between HCA and HCC tissues...
December 28, 2023: Cancers
https://read.qxmd.com/read/38195109/living-donor-liver-transplantation-for-a-large-hepatocellular-carcinoma-in-a-genetically-identical-twin-sister
#35
JOURNAL ARTICLE
Ger Koek, Sophia M Schmitz, Jan Bednarsch, Daniel Heise, Thomas Longerich, Frank Bakers, Christian Trautwein, Tom Luedde, Tom Florian Ulmer, Ulf Peter Neumann
Hepatocellular carcinoma (HCC) is, to date, the most common malignant tumor of the liver and is commonly staged with the Milan criteria. While deceased-donor liver transplantations (DDLT) are reserved for patients within the Milan criteria, living-donor liver transplantation (LDLT) might be a curative option for patients outside the Milan criteria. We here report a case of a 32-year-old woman who developed a giant, unresectable HCC out of a hepatocellular adenoma (HCA) after a pregnancy. The genetically identical twin sister donated her left hemi-liver after ethical approval and preoperative screening...
January 2024: Zeitschrift Für Gastroenterologie
https://read.qxmd.com/read/38194844/to-assess-the-quantitative-features-of-focal-liver-lesions-in-gadoxetic-acid-enhanced-mri-and-to-determine-whether-these-features-can-accurately-differentiate-benign-form-malignant-lesions
#36
JOURNAL ARTICLE
Dorota N Rybczynska, Karolina E Markiet, Joanna M Pienkowska, Edyta Szurowska, Andrzej Frydrychowski
PURPOSE: The study aims at assessing the quantitative features which distinguish focal liver lesions (FLLs) in gadoxetic acid (GA) enhanced liver MRI and at determining whether these features can accurately differentiate benign from malignant lesions. MATERIAL AND METHODS: 107 patients with 180 unequivocal FLLs in previous examinations were included in a single-center retrospective study. All patients underwent a MRI test of the liver with GA. 99 benign and 74 malignant lesions were included...
January 6, 2024: European Journal of Radiology
https://read.qxmd.com/read/38161079/current-level-of-shared-decision-making-in-hepatobiliary-surgical-oncology-sapacha
#37
JOURNAL ARTICLE
Britte H E A Ten Haaft, Alicia Furumaya, Lynn E Nooijen, Geert Kazemier, Dirk T Ubbink, Joris I Erdmann
BACKGROUND: Shared decision-making (SDM) may improve patient autonomy and health outcomes. This study assessed the level of SDM at both ends of the spectrum of hepatobiliary surgery to identify needs and opportunities for improvement. METHODS: A mixed-methods study was performed. Consultations regarding surgery for perihilar cholangiocarcinoma (pCCA) or hepatocellular adenoma (HCA) were prospectively included between September 2020 and December 2022. The level of patient involvement in treatment decision-making was assessed objectively by analysis of audio-recorded consultations using the OPTION-5 instrument...
December 20, 2023: HPB: the Official Journal of the International Hepato Pancreato Biliary Association
https://read.qxmd.com/read/38133879/the-human-gp130-cytokine-receptor-and-its-expression-an-atlas-and-functional-taxonomy-of-genetic-variants
#38
REVIEW
Yin-Huai Chen, Sarah van Zon, Alex Adams, Dirk Schmidt-Arras, Arian D J Laurence, Holm H Uhlig
Genetic variants in IL6ST encoding the shared cytokine receptor for the IL-6 cytokine family GP130 have been associated with a diverse number of clinical phenotypes and disorders. We provide a molecular classification for 59 reported rare IL6ST pathogenic or likely pathogenic variants and additional polymorphisms. Based on loss- or gain-of-function, cytokine selectivity, mono- and biallelic associations, and variable cellular mosaicism, we grade six classes of IL6ST variants and explore the potential for additional variants...
December 22, 2023: Journal of Clinical Immunology
https://read.qxmd.com/read/38133737/patient-with-a-novel-syndrome-with-multiple-benign-hepatic-lesions-and-extrahepatic-neoplasms
#39
JOURNAL ARTICLE
Silvana Wilken, Tharusan Thevathasan, Can Kamali, Adrien Guillot, Jana Ihlow, Uli Fehrenbach, Magdalena Danyel, Johann Pratschke, Frank Tacke, Felix Krenzien
Simultaneous occurrence of benign hepatic lesions of different types is a sporadic phenomenon. To the best of our knowledge, we report the first clinical case of a syndrome with simultaneous manifestations of three different entities of benign liver tumors (hepatocellular adenoma, focal nodular hyperplasia and hemangioma) with a novel mutation detected in the liver adenoma and in the presence of a number of further extrahepatic organ neoplasms. Furthermore, we describe for the first time the presence of liver epithelial cells of hepatocytic phenotype expressing cytokeratin 7 (CK7) at the border of the adenoma...
December 22, 2023: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38131361/emergency-liver-resection-for-non-traumatic-lesions-a-systematic-review
#40
JOURNAL ARTICLE
Andra Ciocan, Simona Margarit, Adrian Bartos, Lidia Ciobanu, Ioana Iancu, Razvan A Ciocan, Nadim Al Hajjar
AIM: Primary liver tumors have an incidence of 20% regarding benign tumors respectively 5.7% of the overall incident cases of cancer. In any major hepatic injury, the surgical treatment has two main goals: hemostasis and excision of the affected liver segments. We aimed to systematic review the non-traumatic emergency liver resections, in order to raise concern about a rather rare, but difficult to treat hepatic pathology, which implies divergent therapeutical approach, and emergency liver surgery remains the first or backup option...
2023: Annali Italiani di Chirurgia
keyword
keyword
118314
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.